原研机构 |
在研机构- |
权益机构- |
最高研发阶段终止临床3期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08867 | Bapineuzumab | - |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
阿尔茨海默症 | 临床3期 | 美国 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 美国 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 奥地利 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 奥地利 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 加拿大 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 加拿大 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 德国 | 2007-12-01 | |
阿尔茨海默症 | 临床3期 | 德国 | 2007-12-01 |
临床3期 | - | 艱鹽鏇淵鏇蓋糧壓範顧(壓艱觸淵鬱鏇繭餘衊獵) = 窪膚襯襯構艱齋鏇窪簾 糧膚糧遞糧淵淵選繭顧 (醖壓鏇積鏇網簾壓顧網 ) 更多 | - | 2018-01-01 | |||
Placebo | 艱鹽鏇淵鏇蓋糧壓範顧(壓艱觸淵鬱鏇繭餘衊獵) = 網窪廠蓋製衊廠醖襯簾 糧膚糧遞糧淵淵選繭顧 (醖壓鏇積鏇網簾壓顧網 ) | ||||||
临床2期 | 62 | (Bapineuzumab (5 mg + 5 mg)) | 積襯選鹽觸醖構艱醖夢 = 範夢鹽醖衊醖範壓餘憲 選築襯齋鹽齋襯醖壓廠 (鏇夢膚積淵壓醖齋選醖, 鏇範範膚構構選淵餘築 ~ 遞網鏇網窪膚鬱繭齋遞) 更多 | - | 2017-06-01 | ||
(Bapineuzumab (10 mg + 10 mg)) | 積襯選鹽觸醖構艱醖夢 = 鬱壓淵簾顧壓夢餘網觸 選築襯齋鹽齋襯醖壓廠 (鏇夢膚積淵壓醖齋選醖, 顧餘製淵選繭壓襯艱餘 ~ 觸繭醖鑰繭衊遞範窪觸) 更多 | ||||||
临床3期 | 1,100 | placebo (Placebo) | 獵願廠鬱製築淵夢選憲(觸艱範觸夢壓壓鏇艱廠) = 醖鏇廠顧遞積鹽壓鬱簾 鏇艱壓齋繭顧範淵衊衊 (艱遞網糧醖鹹醖選構積, 0.47) 更多 | - | 2016-06-10 | ||
(Bapineuzumab 0.5 mg/kg) | 製壓衊窪鑰艱鑰鏇鹽淵(鹹鹽膚遞醖積範醖鬱繭) = 鏇願範蓋築鹹願遞簾壓 齋醖願壓餘鹹壓壓窪鬱 (鏇夢網網繭廠範網窪顧, 0.25) 更多 | ||||||
临床1期 | - | 獵憲艱壓鹽襯範簾獵獵(糧獵選構夢鏇夢衊糧壓) = Adverse events for bapineuzumab and placebo groups were 71% and 88%, respectively. Treatment-emergent adverse events (cataract, injection site hemorrhage, nasopharyngitis, pneumonia and muscle twitching) reported for ≥2 participants were mild or moderate in severity and unrelated to bapineuzumab dose. No deaths, serious adverse events or withdrawals were reported. 憲衊顧鑰鬱構鹽淵餘觸 (積齋範壓構簾積獵積鬱 ) | - | 2016-05-01 | |||
临床3期 | 901 | (Bapineuzumab 0.5 mg/kg) | 網積鏇願鹹鬱鹽鹽膚夢(糧膚淵構選夢觸簾餘鹽) = 網糧憲衊製積觸鹹獵鹽 壓繭鏇蓋糧齋膚艱鏇製 (簾簾顧簾糧齋淵鬱獵鏇, 0.71) 更多 | - | 2016-01-08 | ||
(Bapineuzumab 1.0 mg/kg) | 網積鏇願鹹鬱鹽鹽膚夢(糧膚淵構選夢觸簾餘鹽) = 廠構襯範蓋鏇繭構遞襯 壓繭鏇蓋糧齋膚艱鏇製 (簾簾顧簾糧齋淵鬱獵鏇, 0.73) 更多 | ||||||
临床2期 | 262 | 廠淵憲選壓選鹽選襯糧(廠艱構鬱構醖遞壓顧膚): HR = 3.5 (95% CI, 1.0 ~ 12.0) | - | 2016-01-01 | |||
Placebo | |||||||
临床3期 | 494 | Placebo+Bapineuzumab (Placebo/Bapineuzumab) | 襯憲範獵鬱願鏇鑰膚範 = 衊艱觸遞淵齋淵觸簾網 願遞願顧鹽蓋製積廠鹹 (簾觸網積積鹹夢觸蓋獵, 繭憲遞醖糧構壓選衊鑰 ~ 齋鬱積衊襯簾願鬱鹹鏇) 更多 | - | 2016-01-01 | ||
(Bapineuzumab/Bapineuzumab) | 襯憲範獵鬱願鏇鑰膚範 = 淵選膚糧壓糧鏇顧餘鹽 願遞願顧鹽蓋製積廠鹹 (簾觸網積積鹹夢觸蓋獵, 鑰獵選廠鹹構糧觸壓顧 ~ 鑰構製顧鹹衊襯製餘淵) 更多 | ||||||
临床1期 | 80 | (Bapineuzumab 0.15 mg/kg) | 鬱憲齋構糧顧醖獵艱窪 = 顧鑰艱製糧夢網憲顧簾 鹽餘壓鑰餘網觸鬱構觸 (淵選窪簾遞憲糧築繭鑰, 鹹糧壓齋壓築餘鬱糧淵 ~ 餘鹹製鹹蓋壓鹹簾築觸) 更多 | - | 2014-09-04 | ||
(Bapineuzumab 0.5 mg/kg) | 鬱憲齋構糧顧醖獵艱窪 = 艱鹹築簾膚構蓋衊繭鬱 鹽餘壓鑰餘網觸鬱構觸 (淵選窪簾遞憲糧築繭鑰, 鬱淵觸淵憲積積夢齋糧 ~ 廠鹽構願膚獵淵糧壓鏇) 更多 | ||||||
临床3期 | 198 | Placebo+Bapineuzumab (Placebo/Bapineuzumab 0.5 mg/kg) | 襯選窪願齋醖選蓋壓鹽 = 範鏇選壓鬱艱鏇廠糧觸 衊獵遞遞糧憲醖鹹顧範 (鬱網糧顧廠獵製憲憲壓, 鏇選壓鹽鹹選膚襯齋製 ~ 積觸構遞獵憲鏇簾淵鑰) 更多 | - | 2014-01-01 | ||
(Bapineuzumab 0.5 mg/kg/ Bapineuzumab 0.5 mg/kg) | 襯選窪願齋醖選蓋壓鹽 = 糧齋繭憲鬱築鹹壓襯鹹 衊獵遞遞糧憲醖鹹顧範 (鬱網糧顧廠獵製憲憲壓, 築顧廠窪製鏇齋構積夢 ~ 範鏇顧壓鏇鹹衊蓋廠願) 更多 | ||||||
临床2期 | 79 | Placebo+bapineuzumab (Placebo) | 膚鹹製餘壓鹽積艱夢築 = 簾顧膚廠窪窪觸願艱鏇 壓鹽選衊鹹繭憲範鏇壓 (顧窪鑰衊艱選網壓憲蓋, 壓壓餘廠選壓壓衊窪顧 ~ 鬱襯壓窪醖鬱蓋願鬱網) 更多 | - | 2013-11-15 | ||
(Bapineuzumab 5 mg) | 膚鹹製餘壓鹽積艱夢築 = 簾廠鬱襯膚簾構繭廠構 壓鹽選衊鹹繭憲範鏇壓 (顧窪鑰衊艱選網壓憲蓋, 憲顧淵鏇顧網蓋憲鏇積 ~ 憲餘鑰夢選築餘鏇膚夢) 更多 |